GSE187006 0 V 2 VALPROIC ACID HUMAN UP (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE187006 0 V 2 VALPROIC ACID HUMAN UP.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE187006 0 V 2 VALPROIC ACID HUMAN UP.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE187006 0 V 2 VALPROIC ACID HUMAN UP.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE187006 0 V 2 VALPROIC ACID HUMAN UP.

Results found

Linked to

 

Label

Description

 

Gene

H4 clustered histone 15

Gene

acetylserotonin O-methyltransferase like

Gene

H3.7 histone (putative)

Gene

glucagon like peptide 1 receptor

Gene

short chain dehydrogenase/reductase family 42E, member 1

Gene

neural EGFL like 1

Gene

lecithin retinol acyltransferase

Gene

Sp9 transcription factor

Gene

estrogen receptor binding site associated antigen 9

Gene

interleukin 16

  • Gene

    H4 clustered histone 15


  • Gene

    acetylserotonin O-methyltransferase like


  • Gene

    H3.7 histone (putative)


  • Gene

    glucagon like peptide 1 receptor


  • Gene

    short chain dehydrogenase/reductase family 42E, member 1


  • Gene

    neural EGFL like 1


  • Gene

    lecithin retinol acyltransferase


  • Gene

    Sp9 transcription factor


  • Gene

    estrogen receptor binding site associated antigen 9


  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.